Viewing Study NCT07032792


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-25 @ 1:37 PM
Study NCT ID: NCT07032792
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-24
First Post: 2025-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
Sponsor: Northwell Health
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cardiac Disease View
None Surgery View
None Bleeding View
Keywords: